Your browser doesn't support javascript.
loading
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.
Bröske, Ann-Marie E; Korfi, Koorosh; Belousov, Anton; Wilson, Sabine; Ooi, Chia-Huey; Bolen, Christopher R; Canamero, Marta; Alcaide, Enrique Gomez; James, Ian; Piccione, Emily C; Carlile, David J; Dimier, Natalie; Umaña, Pablo; Bacac, Marina; Weisser, Martin; Dickinson, Michael.
Affiliation
  • Bröske AE; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany.
  • Korfi K; Roche Innovation Center Zürich, Roche Pharma Research and Early Development, Zürich, Switzerland.
  • Belousov A; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.
  • Wilson S; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.
  • Ooi CH; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.
  • Bolen CR; Genentech, Inc., South San Francisco, CA.
  • Canamero M; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany.
  • Alcaide EG; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.
  • James I; A4P Consulting Ltd., Sandwich, United Kingdom.
  • Piccione EC; Genentech, Inc., South San Francisco, CA.
  • Carlile DJ; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom; and.
  • Dimier N; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom; and.
  • Umaña P; Roche Innovation Center Zürich, Roche Pharma Research and Early Development, Zürich, Switzerland.
  • Bacac M; Roche Innovation Center Zürich, Roche Pharma Research and Early Development, Zürich, Switzerland.
  • Weisser M; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany.
  • Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, VIC, Australia.
Blood Adv ; 6(3): 1025-1037, 2022 02 08.
Article in En | MEDLINE | ID: mdl-34941996
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, B-Cell / Antibodies, Bispecific Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Blood Adv Year: 2022 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, B-Cell / Antibodies, Bispecific Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Blood Adv Year: 2022 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos